Increased carotid intima media thickness and cardiac biomarkers in HIV infected children

AIDS

Volumn 21, Issue 8, 2007, Pages 921-927

  McComsey, Grace A ^a,b   O'Riordan, MaryAnn ^a   Hazen, Stanley L ^c   El Bejjani, Dalia ^d   Bhatt, Shweta ^e   Brennan, Marie Luise ^c   Storer, Norma ^a   Adell, Jerome ^d   Nakamoto, Dean A ^d   Dogra, Vikram ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Atherosclerosis; Carotid intima media thickness; HIV; Myeloperoxidase

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HOMOCYSTEINE; LAMIVUDINE; MYELOPEROXIDASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CHILD; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNAL CAROTID ARTERY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; WAIST HIP RATIO;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HOMOCYSTEINE; HUMANS; LIPIDS; MALE; PEROXIDASE; TUNICA INTIMA; TUNICA MEDIA;

EID: 34247626308     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328133f29c     Document Type: Article

References (34)

1. The DAD Writing Committee. Cardio- and cerebrovascular events in HIV infected persons. AIDS 2004; 18:1811-1817.
2. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109:1603-1608.
3. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656.
4. Espeland M, O'leary D, Terry J, Morgan T, Evans G, Mudra H. Carotid intimal media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005; 6:3.
5. Ogata T, Yasaka M, Yamagishi M, Seguchi O, Nagatsuka K, Minematsu K. Atherosclerosis found on carotid ultrasonography is associated with atherosclerosis on coronary intravascular ultrasonography. J Ultrasound Med 2005; 24:469-474.
6. Currier JS, Kendall MA, Zackin R, Henry KW, Alston-Smith B, Toriani FJ, et al. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 2005; 19:927-933.
7. Chironi G, Escaut L, Gariepy J, Cogny A, Monsuez J-J, Levenson J, et al. Carotid intima media thickness in heavily pretreated HIV infected patients. J Acquir Immune Defic Syndr 2003; 32:490-493.
8. Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishenbor MH, et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004; 110:1134-1139.
9. Shishehbor MH, Hazen SL. Inflammatory and oxidative markers in atherosclerosis: relationship to outcome. Curr Atheroscler Rep 2004; 6:243-250.
10. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843.
11. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557-1565.
12. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles SJ, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959-1965.
13. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women. JAMA 1999; 281:1817-1821.
14. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268:877-881.
15. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 1998; 158:862-867.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
17. Riley WA, Barnes RW, Applegate WB, Dempsey R, Hartwell T, Davis VG, et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 1992; 23:1062-1068.
18. O'Leary DH, Polak JF, Wolfson SK, Bond MG, Bommer W, Sheth S, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke 1991; 22:1155-1163.
19. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. New Engl J Med 1998; 338:1650-1656.
20. Jarvisalo MJ, Putto-Laurila A, Jartti L, Lehtimaki T, Solakivi T, Ronnemaa T, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002; 51:493-498.
21. Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 1996; 16:984-991.
22. Charakida M, Donald AE, Green H, Storry C, Clapson M, Caslake M, et al. Early structural and functional changes of the vasculature in HIV infected children. Impact of disease and antiretroviral therapy. Circulation 2005; 112:103-109.
23. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, Blanche S. Arterial stiffness and endothelial dysfunction in HIV infected children. AIDS 2004; 18:1037-1041.
24. Sakaguchi M, Kitagawa K, Nagai Y, Yamagami H, Kondo K, Matsushita K, et al. Equivalence of plaque score and intima-media thickness of carotid ultrasonography for predicting severe coronary artery lesion. Ultrasound Med Biol 2003; 29:367-371.
25. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New Engl J Med 1999; 340:14-22.
26. Jerrard-Dunne P, Markus HS, Steckel DA, Buehler A, von Kegler S, Sitzer M. Early carotid atherosclerosis and family history of vascular disease. Specific effects on arterial sites have implications for genetic studies. Arteriosclerosis, Thrombosis, Vasc Biol 2003; 23:302-306.
27. Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 2003; 34:632-636.
28. Müller F, Svardal AM, Aukrust P, Berge RK, Ueland PM, Froland SS. Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection. Am J Clin Nutr 1996; 63:242-248.
29. Bernasconi E, Uhr M, Magenta L, Ranno A, Telenti A, for the Swiss HIV cohort Study. Homocysteinaemia in HIV infected patients treated with highly active antiretroviral therapy. AIDS 2001; 15:1081-1082.
30. den Heijer M, Brouwer IA, Bos GMJ, Blom HJ, van der Put NMJ, Spaans AP, et al. Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers. Arteriosclerosis, Thrombosis, Vasc Biol 1998; 18:356-361.
31. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286:2136-2142.
32. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349:1595-1604.
33. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108:1440-1445.
34. Blanco JJR, García IS, Cerezo JG, Peña Sánchez de Rivera JM, Anaya PM, Raya PG, et al. Endothelial function in HIV infected patients with low or mild cardiovascular risk. J Antimicrob Chemother 2006; 58:133-139.